BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3523512)

  • 1. Ethnic differences in reactions to drugs and xenobiotics. Other protein variants with pharmacogenetic consequences: albumin and orosomucoid.
    Alván G
    Prog Clin Biol Res; 1986; 214():345-55. PubMed ID: 3523512
    [No Abstract]   [Full Text] [Related]  

  • 2. Capillary electrophoresis frontal analysis: principles and applications for the study of drug-plasma protein binding.
    Østergaard J; Heegaard NH
    Electrophoresis; 2003 Sep; 24(17):2903-13. PubMed ID: 12973793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for binding of certain acidic drugs to alpha 1-acid glycoprotein.
    Urien S; Albengres E; Zini R; Tillement JP
    Biochem Pharmacol; 1982 Nov; 31(22):3687-9. PubMed ID: 7181952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of albumin and alpha-1 acid glycoprotein on elimination of prazosin and antipyrine in the isolated perfused rat liver.
    Oie S; Fiori F
    J Pharmacol Exp Ther; 1985 Sep; 234(3):636-40. PubMed ID: 4032284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SKF 525A displaces drugs from serum alpha 1-acid glycoprotein binding sites.
    Belpaire FM; Chindavijak B; Bogaert MG
    J Pharmacol Exp Ther; 1987 Feb; 240(2):628-30. PubMed ID: 3806415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the variants of alpha 1-acid glycoprotein to its binding of drugs.
    Baumann P; Eap CB
    Prog Clin Biol Res; 1989; 300():379-97. PubMed ID: 2674972
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaceutical-grade albumin: impaired drug-binding capacity in vitro.
    Olsen H; Andersen A; Nordbø A; Kongsgaard UE; Børmer OP
    BMC Clin Pharmacol; 2004 Mar; 4():4. PubMed ID: 15046641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug binding in sera deficient in lipoproteins, albumin or orosomucoid.
    Pike E; Kierulf P; Skuterud B; Bredesen JE; Lunde PK
    Br J Clin Pharmacol; 1983 Sep; 16(3):233-9. PubMed ID: 6626414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipyrine and warfarin disposition in a patient with idiopathic hypoalbuminemia.
    Piroli RJ; Passananti GT; Shively CA; Vesell ES
    Clin Pharmacol Ther; 1981 Dec; 30(6):810-6. PubMed ID: 7307430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug binding to blood proteins: characteristics, roles and pathophysiological changes].
    Tillement JP; Duché JC; Barré J
    Bull Acad Natl Med; 2006; 190(4-5):935-46; discussion 946-7. PubMed ID: 17195618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding of drugs to human serum albumin:XI. The specificity of three binding sites as studied with albumin immobilized in microparticles.
    Sjöholm I; Ekman B; Kober A; Ljungstedt-Påhlman I; Seiving B; Sjödin T
    Mol Pharmacol; 1979 Nov; 16(3):767-77. PubMed ID: 530258
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug binding to plasma proteins.
    Paxton JW
    N Z Med J; 1985 Apr; 98(776):245-8. PubMed ID: 3857503
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of smoking on serum protein composition and the protein binding of drugs.
    Benedek IH; Blouin RA; McNamara PJ
    J Pharm Pharmacol; 1984 Mar; 36(3):214-6. PubMed ID: 6144765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug therapy. Binding of drugs to serum albumin (second of two parts).
    Koch-Weser J; Sellers EM
    N Engl J Med; 1976 Mar; 294(10):526-31. PubMed ID: 765821
    [No Abstract]   [Full Text] [Related]  

  • 16. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM; Moore P; Quon CY
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels.
    Frostell-Karlsson A; Remaeus A; Roos H; Andersson K; Borg P; Hämäläinen M; Karlsson R
    J Med Chem; 2000 May; 43(10):1986-92. PubMed ID: 10821711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum protein binding of diazepam and propranolol in the feto-maternal unit from early to late pregnancy.
    Krauer B; Nau H; Dayer P; Bischof P; Anner R
    Br J Obstet Gynaecol; 1986 Apr; 93(4):322-8. PubMed ID: 3964607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Binding to alpha 1-acid glycoprotein and relevant apparent volume of distribution.
    Bree F; Houin G; Barre J; Riant P; Tillement JP
    Prog Clin Biol Res; 1989; 300():321-36. PubMed ID: 2674968
    [No Abstract]   [Full Text] [Related]  

  • 20. Electrospray ionization mass spectrometry as a tool for determination of drug binding sites to human serum albumin by noncovalent interaction.
    Benkestock K; Edlund PO; Roeraade J
    Rapid Commun Mass Spectrom; 2005; 19(12):1637-43. PubMed ID: 15915474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.